Viridian Therapeutics, Inc.
VRDN
$16.86
-$0.34-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 762.18M | 874.65M | 490.90M | 563.36M | 636.63M |
| Total Receivables | -- | -- | 70.00M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.56M | 19.58M | 11.01M | 15.39M | 20.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 784.74M | 894.23M | 571.91M | 578.75M | 657.24M |
|
|
|||||
| Total Current Assets | 784.74M | 894.23M | 571.91M | 578.75M | 657.24M |
| Net Property, Plant & Equipment | 3.39M | 3.65M | 3.71M | 3.07M | 3.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 888.00K | 1.54M | 1.52M | 506.00K | 489.00K |
| Total Assets | 789.02M | 899.42M | 577.14M | 582.32M | 660.98M |
|
|
|||||
| Total Accounts Payable | 13.31M | 8.68M | 10.06M | 8.52M | 3.89M |
| Total Accrued Expenses | 37.48M | 60.89M | 39.53M | 34.79M | 28.92M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 738.00K | 753.00K | 730.00K | 8.99M | 536.00K |
| Total Finance Division Other Current Liabilities | 274.00K | 367.00K | 372.00K | 288.00K | 388.00K |
| Total Other Current Liabilities | 274.00K | 367.00K | 372.00K | 288.00K | 388.00K |
| Total Current Liabilities | 51.81M | 70.70M | 50.70M | 52.59M | 33.73M |
|
|
|||||
| Total Current Liabilities | 51.81M | 70.70M | 50.70M | 52.59M | 33.73M |
| Long-Term Debt | 50.44M | 49.94M | 20.89M | 12.35M | 20.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.18M | 1.90M | 2.58M | 1.74M | 1.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.59M | 54.72M | -- | 477.00K | 212.00K |
| Total Liabilities | 153.01M | 177.25M | 74.17M | 67.16M | 56.51M |
|
|
|||||
| Common Stock & APIC | 1.95B | 1.93B | 1.53B | 1.51B | 1.50B |
| Retained Earnings | -1.44B | -1.34B | -1.22B | -1.18B | -1.08B |
| Treasury Stock & Other | -558.00K | 447.00K | 363.00K | 69.00K | 245.00K |
| Total Common Equity | 503.95M | 590.11M | 314.09M | 326.28M | 415.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 132.06M | 132.06M | 188.89M | 188.89M | 188.89M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 132.06M | 132.06M | 188.89M | 188.89M | 188.89M |
|
|
|||||
| Total Common Equity | 503.95M | 590.11M | 314.09M | 326.28M | 415.59M |
| Total Preferred Equity | 132.06M | 132.06M | 188.89M | 188.89M | 188.89M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 636.01M | 722.17M | 502.97M | 515.17M | 604.47M |
|
|
|||||